Soluble factors (cytokines) produced by lymphocytes and monocytes exert a wide range of immunologic activities that could alter the allograft response. While the nature of the cells infiltrating rejecting organs has been extensively studied, their pattern of cytokine production and the influence of these factors on the rejection process are less well evaluated. To define the dynamics of cytokine production in the allograft situation and its functional consequences, 4 specific aims are proposed: 1) Develop quantitative molecular biology techniques for measuring cytokine production in situ using as an initial model murine graft-vs-host disease. By Northern blot analysis, in situ hybridization and bioassay techniques, cytokine production at the mRNA as well as protein level will be assessed. 2) Assess functional properties of monocytes in spleens of mice undergoing GVH disease, since these cells are prominent in rejecting organs and are targets of cytokine action. Monocyte function will be correlated with levels of various factors measured. 3) Assess B cell expression in GVH disease. Certain forms of GVH are associated with autoantibody production and we wish to determine whether this pattern of preferential antibody expression is related to the pattern of cytokine production. We will also evaluate cyclosporine sensitivity of B cells in this disease model. 4) With techniques developed in the GVH model, we will investigate cytokine mRNA production in various solid graft models studied in this Program Project. Together these studies should clarify the role of a series of potent immunoregulatory molecules that could modify the course of transplant rejection.

Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Kirk, A D; Bollinger, R R; Finn, O J (1995) Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute renal allograft rejection. Hum Immunol 43:113-28
Pruitt, S K; Kirk, A D; Bollinger, R R et al. (1994) The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57:363-70
Pruitt, S K; Baldwin 3rd, W M; Barth, R N et al. (1993) The effect of xenoreactive antibody and B cell depletion on hyperacute rejection of guinea pig-to-rat cardiac xenografts. Transplantation 56:1318-24
Spurney, R F; Onorato, J J; Ruiz, P et al. (1993) Characterization of glomerular thromboxane receptors in murine lupus nephritis. J Pharmacol Exp Ther 264:584-90
Gravatt, L C; Chaffee, S; Hebert, M E et al. (1993) Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model. Leukemia 7:1261-7
Kirk, A D; Li, R A; Kinch, M S et al. (1993) The human antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness. Transplantation 55:924-31
Pruitt, S K; Weinstock, D; Suyemoto, M M et al. (1993) Effect of bursectomy on deposition of natural xenoreactive antibodies and complement within rat cardiac xenografts in the chicken. Transplant Proc 25:435-7
Messina, J P; Gilkeson, G S; Pisetsky, D S (1993) The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens. Cell Immunol 147:148-57
Kirk, A D; Heinle, J S; Mault, J R et al. (1993) Ex vivo characterization of human anti-porcine hyperacute cardiac rejection. Transplantation 56:785-93
Brauer, R B; Baldwin 3rd, W M; Daha, M R et al. (1993) Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol 151:7240-8

Showing the most recent 10 out of 92 publications